Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Ingredients News

Aerie to build manufacturing facility in Ireland

11-Jan-2017 - Aerie Pharmaceuticals Inc will lease a 30,000 sq ft manufacturing facility in Ireland to commercialise its eye-drop product for Glaucoma after delays at a third party CMO.

Novo Nordisk hires Fluor to build giant US diabetes drug API plant

10-Jan-2017 - Novo Nordisk has hired Fluor Corporation to design and build the diabetes drug API plant it is setting up in Clayton, North Carolina.

Patented biosynthesis produces 'authentic, standardized cannabinoids' for pharma

05-Jan-2017 - Teewinot’s Irish subsidiary has been granted a fourth patent for a pharmaceutical cannabinoid manufacturing technique which it says saves both time and money.

Out with the old, in with the new? Lonza sells peptide biz, Recipharm adds Indian ops

05-Jan-2017 - Recipharm receives approval to buy Kemwell’s Indian operations and PolyPeptides completes the acquisition of Lonza’s peptide business. Welcome to in-Pharmatechnologist’s 2017 M&A round-up.

Lonza contracted to make API for Aurinia's lupus nephritis candidate

21-Dec-2016 - Lonza has been contracted to the API for a candidate lupus nephritis treatment by Canadian developer Aurinia Pharmaceuticals Inc. 

Wacker adding cysteine capacity through Spanish acquisition

21-Dec-2016 - Wacker says it is buying a large-scale fermentation facility in Spain to support growing demand for the amino acid cysteine.

US FDA has concerns about Granules - Ajinomoto OmniChem's Vizag API plant

20-Dec-2016 - US FDA inspectors have raised questions about an API manufacturing facility in India that is operated by Granules India and Ajinomoto OmniChem.

Strides Shasun buys Perrigo’s US FDA-approved API plant in India

19-Dec-2016 - Bangalore’s Strides Shasun Ltd. has acquired Perrigo API India ltd and its active pharmaceutical manufacturing portfolio for generics for INR1bn ($14.7m).


Sugar lumps? Excipient impurities may be risk to patients says researcher

14-Dec-2016 - Newly identified impurities in sugar excipients pose a risk to patients and could explain why some drugs fail safety tests according to scientists from the Netherlands.

News in brief

CMO Evonik acquires silica business for $630m

13-Dec-2016 - Evonik Industries AG has acquired the silica business from the US company J.M. Huber, expanding the company’s presence in North America and Asia.

Skanska gets $45m contract to refit US GSK R&D hub

13-Dec-2016 - GSK has hired Skanska AB to renovate its laboratory and office in Upper Providence, Pennsylvania, US in a $45m (€42m) project.

Saneca gets Gov grant to invest in API plant

13-Dec-2016 - The Slovakian Government has granted Saneca Pharma €1.5m ($1.6m) to invest in ‘green’ API manufacturing and anti-abuse technologies for its opiate-based drugs.  

News in brief

Alkem issued with Form 483 by US FDA

12-Dec-2016 - The US FDA has issued Indian API firm Alkem Laboratories Ltd. with a Form 483 after an inspection at is site in Ankleshwar, Gujarat.

Lonza to sell therapeutic peptides business to PolyPeptide

07-Dec-2016 - Lonza has agreed to sell its therapeutic peptide business to PolyPeptide Laboratories in a deal that will also see the latter firm take on 280 staff.

US FDA says Interquim's API plant remediation plan is inadequate

06-Dec-2016 - The US FDA has asked Spanish API firm Interquim S.A. for more details of its plan to bring its Barcelona manufacturing plant up to code.

Merck launches HME excipient with high API loading capacity

06-Dec-2016 - Merck has launched a polyvinyl alcohol-based excipient developed for use in drugs produced via hot melt extrusion (HME).

Italian PM's resignation will hit API sector if anti-EU party takes power says expert

05-Dec-2016 - Italian PM Matteo Renzi has quit after voters rejected his controversial plan for parliamentary reforms, setting the stage for political and economic turmoil.


Ita-leave? Italian referendum may impact European API supply chain

02-Dec-2016 - A ‘no’ vote in the Italian constitutional referendum this weekend may hurt the country's API industry and impact European drug supply chains.

News in brief

Ecstasy to treat PTSD by 2021? US FDA approves Ph III trial

01-Dec-2016 - Party drug MDMA has been claimed to be effective in helping treat Post-traumatic stress disorder (PTSD) patients, with the FDA approval for a Ph III trial to go ahead in the US.

US FDA slams Dongying Tiandong for poor raw heparin supplier oversight

30-Nov-2016 - Dongying Tiandong Pharmaceutical Co., Ltd does not do enough to ensure the crude heparin it uses is free potentially lethal contaminant OSCS according to the US FDA.

News in brief

AMRI signs second API supply deal with Shire

29-Nov-2016 - AMRI has signed a second deal with Shire plc under which it will supply an undisclosed active pharmaceutical ingredient (API).


Patheon buys Roche's Xeloda API plant and signs supply deal

29-Nov-2016 - Patheon has bought a US API facility from Roche in a deal that will also see the CMO supply the Swiss firm with drug ingredients.

News in brief

Nitika to build 4th excipients plant near emerging Indian export hub

28-Nov-2016 - Nitika Pharmaceutical Specialties Pvt Ltd has said it will build a fourth pharmaceutical excipients plant in Nagpur, India.

US FDA says Srikem plan will not fix data integrity issues at Taloja plant

24-Nov-2016 - The US FDA still has doubts about Srikem Laboratories’ plan to fix data integrity problems at its API manufacturing facility Taloja, India.

Sun buys stake in Russian API and drug firm JSC Biosintez

23-Nov-2016 - Sun Pharma has announced it will buy a controlling interest in Russian drug and API manufacturer JSC Biosintez to access local market.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...